Skip to main content
Clinical Trials/ITMCTR2000004000
ITMCTR2000004000
Not yet recruiting
Phase 1

Clinical study on the precise diagnosis and treatment of nonalcoholic fatty liver disease with Trinity therapy combined with fibrotouth Technology

Shanghai Hospital of Traditional Chinese Medicine0 sitesTBD

Overview

Phase
Phase 1
Intervention
Not specified
Conditions
Not specified
Sponsor
Shanghai Hospital of Traditional Chinese Medicine
Status
Not yet recruiting
Last Updated
3 years ago

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
TBD
End Date
TBD
Last Updated
3 years ago
Study Type
Interventional study
Sex
All

Investigators

Sponsor
Shanghai Hospital of Traditional Chinese Medicine

Eligibility Criteria

Inclusion Criteria

  • 1\) Patients with nonalcoholic fatty liver disease who meet the above diagnostic criteria of Western medicine.
  • 2\) Aged between 18\-55 years old, can adhere to the treatment, no allergy to traditional Chinese medicine.
  • 3\) Patients with good compliance and complete clinical data required for follow\-up.

Exclusion Criteria

  • 1\) The patients with drinking history or alcohol equivalent alcohol volume less than 40g per week;
  • 2\) Those aged less than 18 years or more than 65 years;
  • 3\) Women who are lactating or pregnant or planning to be pregnant;
  • 4\) Those who need long\-term medication for hypertension, diabetes, heart disease and blood system diseases;
  • 5\) Serum transaminase (alt, AST) increased at 80u /L;
  • 6\) Patients with viral hepatitis, drug\-induced liver disease, Wilson's disease, total parenteral nutrition and autoimmune liver disease;
  • 7\) Patients who have received other related drug treatment.

Outcomes

Primary Outcomes

Not specified

Similar Trials